The Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, are joined by Muhammad Shaalan Beg, MD, to discuss recent data updates in gastrointestinal cancers from clinical trials presented at the 2023 ASCO Annual Meeting.
EP. 1: PROSPECT: Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Muhammad Shaalan Beg, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss recent data from the PROSPECT trial investigating neoadjuvant therapy regimens for the treatment of locally advanced rectal cancer.
EP. 2: NORPACT-1: Neoadjuvant Chemotherapy for Resectable Pancreatic Head Cancer
Expert oncologists review recent data from the NORPACT-1 study on the use of neoadjuvant FOLFIRINOX chemotherapy for patients with resectable pancreatic head cancer.
EP. 3: NAPOLI-3: Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
A review of recent data from NAPOLI-3 comparing the NALIRIFOX chemotherapy regimen versus nab-paclitaxel plus gemcitabine for patients with metastatic pancreatic ductal adenocarcinoma.
EP. 4: IMbrave050: Adjuvant Therapy for High-Risk Hepatocellular Carcinoma
The Oncology Brothers, joined by Muhammad Shaalan Beg, MD, share their thoughts on data from the IMbrave050 trial investigating adjuvant atezolizumab plus bevacizumab in patients with high-risk hepatocellular carcinoma.
EP. 5: Closing Thoughts on Recent Data in GI Cancer
Rohit Gosain, MD, and Rahul Gosain, MD, provide a summary of the key gastrointestinal cancer data updates discussed following the 2023 ASCO Annual Meeting.
2 Clarke Drive Cranbury, NJ 08512